<DOC>
	<DOC>NCT00537524</DOC>
	<brief_summary>Evaluate the immune response and reactogenicity of H5N1 vaccination in subjects aged 6 months to 17 years compared to seasonal flu vaccination</brief_summary>
	<brief_title>Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Influenza in Birds</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy subjects Receipt of Seasonal Influenza Vaccine for season 2007/2008 Receipt of another vaccine within 3 weeks before and after each vaccination Previous vaccination with a pandemic candidate vaccine and/or vaccine containing the adjuvant MF59 or a similar adjuvant Children who are in the local recommendation for influenza vaccination due to underlying diseases</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Bird flu</keyword>
	<keyword>seasonal influenza vaccine</keyword>
	<keyword>influenza vaccine</keyword>
	<keyword>prepandemic vaccine</keyword>
	<keyword>virus strain with the potential to cause pandemic</keyword>
	<keyword>toddlers</keyword>
	<keyword>children</keyword>
	<keyword>adolescents</keyword>
</DOC>